Target intelligence / Profile preview

Connexin gap junction channel (Connexin (Cx))

Target
Connexin (Cx)
Molecular classification
Ion channel, Gap junction channel, Membrane protein, Four-helix transmembrane channel
01

Overview

Connexin gap junction channels are formed by the docking of two hemichannels (connexons), each composed of six connexin proteins, between neighboring cells, creating a direct cytoplasmic connection that allows ions and small metabolites (up to ~1 kDa) to pass between cells, facilitating electrical and metabolic coupling[4][5][7]. There are at least 21 connexin isoforms in humans, with connexin43 (Cx43), connexin26 (Cx26), and connexin32 (Cx32) being some of the best studied[4][5][2]. Gap junction channels are crucial for synchronized cell function in the heart, brain, liver, and other tissues[4][5]. Individual connexin channels display unique permeability, gating, and selectivity properties[5]. They are regulated by voltage, pH, calcium ions, phosphorylation, and various metabolites[3][1]. Mutations or dysregulation of connexins are linked to diverse diseases, including arrhythmias, cancer, deafness, and skin disorders[2][4]. Drugs may block or modulate connexin channels, but clinical use is limited due to challenges in isoform specificity and broad tissue distribution[4].

Other names
Gap junction channelConnexin channelGap junction proteinGap junctionCx channel
02

Mechanism of action

Channel blockage (inhibition of ion and molecule passage through the channel) Modulation of channel gating Alteration of phosphorylation or degradation Disruption of intercellular coupling

03

Biological functions

Intercellular communicationElectrical couplingChemical signal transmissionRegulation of cell proliferationRegulation of apoptosisCell synchronization
04

Disease associations

Cardiovascular diseaseCancerNeurodegenerative diseaseSkin disordersHearing lossInflammation
05

Safety considerations

Non-specific inhibition affects multiple tissue systemsEssential physiological roles (risk of arrhythmias, impaired cell signaling)Toxicity due to widespread connexin expression
06

Interacting drugs

Carbenoxolone

4 more in the full profile.

07

Biomarkers

Connexin43 (Cx43) expression levels (esp. in cardiac pathology or cancer)Connexin26 (Cx26) mutations (notably in skin and hearing disorders)

Beyond the preview

Go deeper on Connexin gap junction channel (Connexin (Cx)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Connexin gap junction channel (Connexin (Cx)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call